BMY vs NVST
Bristol Myers Squibb vs Envista Holdings — AI-powered side-by-side comparison
| Metric | BMY | NVST |
|---|---|---|
| AI Score | 62 | 72 |
| Price | $64.70 | $28.14 |
| P/E Ratio | 14.13× | 46.41× |
| ROE | 38.2% | 1.5% |
| Revenue Growth YoY | — | — |
| Gross Margin | 70.2% | 55.5% |
| Debt / Equity | 1.93× | 0.52× |
| Dividend Yield | 3.9% | 0.0% |
| RSI (14) | 58.7 | 50.5 |
| Beta | 0.235 | 0.861 |
| Expected Upside | +3.2% | +4.5% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
NVST Full Analysis